Covington Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-41,440
Closed -$1.88M 96
2019
Q2
$1.88M Buy
41,440
+275
+0.7% +$12.8K 0.61% 65
2019
Q1
$1.96M Buy
41,165
+1,220
+3% +$60.8K 0.66% 61
2018
Q4
$2.08M Sell
39,945
-69
-0.2% -$3.71K 0.79% 59
2018
Q3
$2.48M Buy
40,014
+300
+0.8% +$17.8K 0.81% 59
2018
Q2
$2.2M Hold
39,714
0.75% 61
2018
Q1
$2.51K Buy
39,714
+1,455
+4% +$93.6K 0.81% 55
2017
Q4
$2.35M Buy
38,259
+950
+3% +$59.4K 0.8% 57
2017
Q3
$2.38M Sell
37,309
-355
-0.9% -$20.7K 0.9% 53
2017
Q2
$2.1M Sell
37,664
-100
-0.3% -$5.44K 0.8% 61
2017
Q1
$2.05M Buy
37,764
+105
+0.3% +$5.76K 0.82% 60
2016
Q4
$2.2M Sell
37,659
-910
-2% -$49.8K 0.93% 48
2016
Q3
$2.08M Buy
38,569
+1,585
+4% +$102K 0.95% 51
2016
Q2
$2.72M Sell
36,984
-350
-0.9% -$24.7K 1.2% 42
2016
Q1
$2.38M Sell
37,334
-815
-2% -$51.4K 1.08% 48
2015
Q4
$2.62M Sell
38,149
-620
-2% -$41K 1.21% 43
2015
Q3
$2.29M Sell
38,769
-450
-1% -$28.5K 1.22% 38
2015
Q2
$2.61M Sell
39,219
-96
-0.2% -$6.33K 1.63% 23
2015
Q1
$2.54M Sell
39,315
-19,940
-34% -$1.25M 1.75% 15
2014
Q4
$3.5M Hold
59,255
1.92% 12
2014
Q3
$3.03M Buy
59,255
+210
+0.4% +$10.5K 1.75% 18
2014
Q2
$2.86M Sell
59,045
-210
-0.4% -$10.3K 1.66% 23
2014
Q1
$3.08M Hold
59,255
1.82% 16
2013
Q4
$3.15M Sell
59,255
-350
-0.6% -$17.8K 2.02% 12
2013
Q3
$2.76M Buy
59,605
+595
+1% +$26.1K 1.88% 18
2013
Q2
$2.64M Buy
+59,010
New +$2.56M 1.84% 18

Other funds holding BMY

Covington Investment Advisors's BMY Position: Q3 2019 in Review

Covington Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 41,440 shares — an estimated $1.88M sold.

Covington Investment Advisors first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $3.5M in Q4 2014. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Covington Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
  • Covington Investment Advisors sold 41,440 Bristol-Myers Squibb shares in Q3 2019, an estimated $1.88M.
  • Covington Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
  • Covington Investment Advisors's Bristol-Myers Squibb position peaked at $3.5M in Q4 2014.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Covington Investment Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.